Chronic exposure to nicotine from tobacco use can cause liver damage and inflammation, primarily through complex molecular pathways that promote cell death and inflammation.
This article explains how dexpanthenol may counteract these effects by modulating key pathways such as Bax/Bcl-xL, Caspase-3/9, and Akt/NF-?B, potentially offering a protective strategy against liver injury.
This page provides an explainer summary based on the available research paper information. It is not a copy of the original paper. For complete methodology, data, findings, and full text, please visit the original source.
View Original SourceChoose how you want to understand this article. The AI can explain it in simple language, Urdu, bullet points, Q&A, policy brief, or research-style notes using the available explainer content and original source link where possible.
This feature is powered by AI and is intended to help readers better understand research papers, reports, articles, and public-health information. AI-generated responses may occasionally be incomplete or limited. This feature does not replace the original source, medical advice, professional research review, or official policy guidance. For complete methodology, data, findings, and full text, please refer to the original source.